Published: 2024-12-25 2024-12-25 On the 24th, SINEW PHARMA announced that its innovative pain relief drug, SNP-810, a high-liver-safety acetaminophen, has successfully completed toxicology testing on large animals (dogs) conducted by the globally renowned Charles River Laboratories. The results confirmed that the drug maintains excellent safety even at extremely high doses (equivalent to 38 tablets of...Read More

Published: 2024-07-08 Diamond Biofund (TWSE:6901) announced today the signing of a Memorandum of Understanding (MoU) with French biotech venture fund – AdBio Partners (www.adbio.partners). Both parties announced the establishment of a cross-border investment cooperation to facilitate flagship investments in the biotech and medical sectors. AdBio Partners (formerly Advent France Biotechnology) was established in Paris in...Read More

Published: 2024-06-19   No 1 Date of announcement 2024/06/19 Time of announcement 15:25:07 Subject The Company announces the information about the investor conference of Q2, 2024. Date of events 2024/06/19 To which item it meets paragraph 12 Date of institutional investor conference:2024/06/26 Time of institutional investor conference:15:00 (GMT+8) Location of institutional investor conference:Online investor conference...Read More

Published: 2024-05-23 NEWS PROVIDED BY StemCyte May 23, 2024, 11:47 ET BALDWIN PARK, Calif., May 23, 2024 /PRNewswire/ — StemCyte, a leader in cord blood-based regenerative therapeutics in Southern California, is excited to announce the renewal of its partnership with the California State Umbilical Cord Blood Collection Program (CA-UCBCP). In collaboration with UC Davis Health,...Read More